Mirati Therapeutics, Inc.·4

Jun 26, 8:26 PM ET

Mirati Therapeutics, Inc. 4

4 · Mirati Therapeutics, Inc. · Filed Jun 26, 2017

Insider Transaction Report

Form 4
Period: 2017-06-22
Reisman Neil
10% Owner
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2017-06-22+25,00025,000 total
    Exercise: $4.05Exp: 2027-06-21Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the Option vest and become exercisable in 36 equal monthly installments following the date of grant.

Documents

2 files